AI Networking Cookbook: Practical recipes for AI-assisted network automation and development
TL;DR
A novel palmitoylation-dependent mechanism regulating TGF-β1-Smad signaling in lung cancer is identified and upregulating the ZDHHC11-PPM1A axis or targeting USP5 may offer new strategies to inhibit metastasis in lung cancer.
TGFBR3 interacts with FATP2 and is associated with the regulation of migration and invasion in lung cancer cells, potentially involving the FATP2-ACSL1 axis.
Findings reveal a potential RNF113A/SNIP1/TGF-β regulatory axis and highlight RNF113A as a potential therapeutic target in CRC, warranting further mechanistic validation.
Findings identify a novel PRDX1-PRMT5 axis that activates Wnt/β-catenin signaling, highlighting a potential therapeutic strategy for CRC by targeting this pathway to suppress tumor progression and remodel the immune microenvironment.
This study identifies TXNRD1 as a crucial regulator of cellular plasticity and metastasis in NSCLC via the TGF-β1 pathway, suggesting that targeting TXNRD1 may reduce metastatic potential and improve patient survival.
In vivo, METTL3 overexpression promoted tumor growth, reduced 4-HNE levels, and regulated ferroptosis and FAK/MAPK/ERK pathway proteins, all of which were reversed by COL5A2 knockdown.
Findings define AMOTL2 as a potential suppressor of GC progression that is destabilized by SMURF1, suggesting that the SMURF1-AMOTL2-Smad signaling axis may contribute to GC progression and lymphatic dissemination, representing a candidate therapeutic target that warrants further validation.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.